Ascorbic Acid Deficiency — Patent Landscape
1
Approved drugs
11
Active US patents
40/100
Avg vulnerability
—
Annual revenue covered
Originators in Ascorbic Acid Deficiency
Cliff calendar — next 15 years
5
32
6
33
Approved drugs ranked by patent estate
| Drug | Originator | Active patents | Avg vuln | Revenue | First cliff |
|---|---|---|---|---|---|
|
Infuvite Adult
ASCORBIC ACID
|
— | 11 | 40 | — | 2032-03-09 |
Most attackable patents
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 11529368 | Infuvite Adult | method of use | 59 | 2032-03-09 |
| 12083179 | Infuvite Adult | method of use | 58 | 2033-09-10 |
| 10792306 | Infuvite Adult | method of use | 51 | 2032-03-09 |
| 9592252 | Infuvite Adult | method of use | 45 | 2032-08-11 |
| 10918723 | Infuvite Adult | method of use | 45 | 2033-09-10 |
| 9326969 | Infuvite Adult | method of use | 45 | 2033-09-10 |
| 10780112 | Infuvite Adult | formulation | 31 | 2032-03-09 |
| 10646512 | Infuvite Adult | formulation | 31 | 2032-03-25 |
| 8999313 | Infuvite Adult | formulation | 25 | 2033-09-10 |
| 9707297 | Infuvite Adult | formulation | 25 | 2033-09-10 |
Strongest defences
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 9707297 | Infuvite Adult | formulation | 25 | 2033-09-10 |
| 10016504 | Infuvite Adult | formulation | 25 | 2033-09-10 |
| 8999313 | Infuvite Adult | formulation | 25 | 2033-09-10 |
| 10646512 | Infuvite Adult | formulation | 31 | 2032-03-25 |
| 10780112 | Infuvite Adult | formulation | 31 | 2032-03-09 |
| 10918723 | Infuvite Adult | method of use | 45 | 2033-09-10 |
| 9326969 | Infuvite Adult | method of use | 45 | 2033-09-10 |
| 9592252 | Infuvite Adult | method of use | 45 | 2032-08-11 |
| 10792306 | Infuvite Adult | method of use | 51 | 2032-03-09 |
| 12083179 | Infuvite Adult | method of use | 58 | 2033-09-10 |
Related
- Ascorbic Acid Deficiency — full disease profile
- AI Patent Landscape Report — type "ascorbic acid deficiency" for an AI exec memo
- Company Patent Rankings
- Biosimilar Opportunity Scanner